News tagged with cancer center

BRCAPRO model underestimates BRCA1/2 mutation risk

(HealthDay)—Use of the BRCAPRO model for assessment of the likelihood of having a germline BRCA1/BRCA2 mutation, based on age, ethnicity, and family history, may underestimate the risk of mutations, ac ...

Mar 21, 2014
popularity 0 comments 0

COXEN model picks the best drug for ovarian cancer

There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug ...

Feb 18, 2014
popularity 0 comments 0